Palisade Bio

Call Directions Website Contact the business

Palisade Bio Palisade Bio (Nasdaq: PALI) is advancing next-generation oral PDE4 inhibitor prodrugs for inflammatory and fibrotic diseases.

Palisade Bio Presents Rapid Endoscopic Improvement and New Translational Evidence for PALI-2108 in Inflammatory Bowel Di...
10/20/2026

Palisade Bio Presents Rapid Endoscopic Improvement and New Translational Evidence for PALI-2108 in Inflammatory Bowel Disease at UEG Week 2026

https://bit.ly/480y5Zc

Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rati...
10/12/2026

Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026

https://bit.ly/4dAswUE

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG W...
09/28/2026

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

https://bit.ly/3TszDaQ

Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearancehttps://bit.ly/4AsKL83         ...
09/23/2026

Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance

https://bit.ly/4AsKL83

Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBDhtt...
09/22/2026

Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD

https://bit.ly/4xEMEMm

Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forumhttps://bit.ly/4rrrboP
09/21/2026

Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum

https://bit.ly/4rrrboP

 Palisade Bio’s J.D. Finley and Mitchell L. Jones joined The BioHub by Avetix for a conversation on the progress of PALI...
09/11/2026



Palisade Bio’s J.D. Finley and Mitchell L. Jones joined The BioHub by Avetix for a conversation on the progress of PALI-2108 and what lies ahead as we advance toward our Phase 2 ASCENTRA-UC study.

Listen to the full episode: https://bit.ly/4h5DgfJ

We were featured on the The BioHub Podcast by Avetix! It was a great opportunity to discuss the progress of PALI-2108 an...
09/02/2026

We were featured on the The BioHub Podcast by Avetix! It was a great opportunity to discuss the progress of PALI-2108 and what we believe it could mean for the future of ulcerative colitis treatment.

Listen here: https://bit.ly/4h5DgfJ

08/11/2026

“The second quarter marked a decisive transition for Palisade Bio as we completed the regulatory and operational work required to advance PALI-2108 into Phase 2 development,” said JD Finley, Chief Executive Officer of Palisade Bio. Read more: https://bit.ly/4gnvhua

Address

5800 Armada Drive, Suite 210
Carlsbad, CA
92008

Alerts

Be the first to know and let us send you an email when Palisade Bio posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Palisade Bio:

Shortcuts

Share